Benjamin Kelmendi, Terence Ching
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Family involvement in psychedelic therapy can optimize outcomes and prevent problematic patterns. Ethical, neurobiological, and psychological aspects, along with clinical trial data, support the benefits of engaging family members.
Jennifer Danby
Four sources of data explore scientific findings on psychedelic-mediated personality change. Results from meta-analytic project, clinical trial, observational findings, and qualitative reports are discussed, along with underlying mechanisms and limitations.
Brandon Weiss
Psychedelics are studied for psychiatric disorders; research emphasizes 'set and setting.' Study explores psychosocial factors in psychedelic use, linking communal experiences to improved mental health outcomes.
Hannes Kettner
Results from the largest prospective survey of psilocybin use show that 30% of participants found the experience highly meaningful at 2-4 weeks, with positive effects on mental health persisting at
Sandeep Nayak, Nathan Sepeda, David Mathai
Psilocybin study shows personality changes and increased self-compassion in alcohol use disorder patients. Larger studies needed to confirm impact on AUD outcomes.
Broc A Pagni
Research on psilocybin mushroom use in Mesoamerica explores archeological evidence from Maya, Mixtecs, and Aztecs through various sources, aiming to encourage interpretations based on scientific evidence and a humanistic approach.
Osiris Sinuhé González Romero
Psychedelics, historically linked to "free love", show potential for positive impact on sexual feelings. Recent research suggests psilocybin may enhance sexual functioning and satisfaction in healthy and depressed individuals.
Tommaso Barba
Amanda Feilding, Founder of the Beckley Foundation, drives the Psychedelic Renaissance with groundbreaking research programs at top institutions worldwide, including pioneering studies on psilocybin, LSD, MDMA, and DMT.
Paul discusses the historical use and potential for neurological health of psilocybin mushrooms, based on his team's molecular research and clinical studies at MycoMedica Life Sciences.